Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma × pertuzumab × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 4 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 HER2-positive Breast Cancer 2 Triple Negative Breast Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Malignant Solid Neoplasm 1 Hemangiosarcoma 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Early Breast Cancer 1 Endometrial Neoplasms 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Specimen Handling 6 Cyclophosphamide 5 Biopsy 5 Temozolomide 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 pazopanib 3 X-Rays 3 Vincristine 3 Trabectedin 3 Irinotecan 3 Ifosfamide 3 Doxorubicin 3 regorafenib 2 pembrolizumab 2 fludarabine 2 atezolizumab 2 Sirolimus 2 Radiation 2 Phantoms, Imaging 2 Metastasectomy 2 Interleukin-15 2 Gemcitabine 2 Etoposide 2 trastuzumab deruxtecan 1 tivozanib 1 temsirolimus 1 tazemetostat 1 talimogene laherparepvec 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡